SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-009598
Filing Date
2023-03-24
Accepted
2023-03-24 07:27:43
Documents
14
Period of Report
2023-03-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K oncr-20230324.htm   iXBRL 8-K 58769
2 EX-99.1 oncr-ex99_1.htm EX-99 201476
3 GRAPHIC img130253335_0.jpg GRAPHIC 4325
  Complete submission text file 0000950170-23-009598.txt   394192

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oncr-20230324_lab.xml EX-101.LAB 13350
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oncr-20230324_pre.xml EX-101.PRE 9830
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oncr-20230324.xsd EX-101.SCH 2454
8 EXTRACTED XBRL INSTANCE DOCUMENT oncr-20230324_htm.xml XML 4691
Mailing Address 4 CORPORATE DRIVE ANDOVER MA 01810
Business Address 4 CORPORATE DRIVE ANDOVER MA 01810 857-320-6400
Oncorus, Inc. (Filer) CIK: 0001671818 (see all company filings)

IRS No.: 473779757 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39575 | Film No.: 23757662
SIC: 2834 Pharmaceutical Preparations